<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="editorial" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nodgo</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал детской гематологии и онкологии (РЖДГиО)</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Pediatric Hematology and Oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2311-1267</issn><issn pub-type="epub">2413-5496</issn><publisher><publisher-name>LTD “Graphica”</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nodgo-835</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИНФОРМАЦИОННЫЕ ПИСЬМА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INFORMATION LETTERS</subject></subj-group></article-categories><title-group><article-title>Лечение инфантильных гемангиом</article-title><trans-title-group xml:lang="en"><trans-title>Treatment of infantile hemangiomas</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Редакционная</surname><given-names>статья</given-names></name><name name-style="western" xml:lang="en"><surname>Editorial</surname><given-names>Article</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>16</day><month>08</month><year>2022</year></pub-date><volume>9</volume><issue>2</issue><fpage>106</fpage><lpage>106</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Редакционная с., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Редакционная с.</copyright-holder><copyright-holder xml:lang="en">Editorial a.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nodgo.org/jour/article/view/835">https://journal.nodgo.org/jour/article/view/835</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Регистрационное удостоверение препарата Гемангиол № ЛП-003301 от 10.11.2015.</mixed-citation><mixed-citation xml:lang="en">Регистрационное удостоверение препарата Гемангиол № ЛП-003301 от 10.11.2015.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Котлукова Н.П. и др. Новый взгляд на лечение инфантильных гемангиом (сосудистых гиперплазий)//Педиатрия. Журнал им. Г.Н. Сперанского. – 2012. – Т. 91. – №. 6.</mixed-citation><mixed-citation xml:lang="en">Котлукова Н.П. и др. Новый взгляд на лечение инфантильных гемангиом (сосудистых гиперплазий)//Педиатрия. Журнал им. Г.Н. Сперанского. – 2012. – Т. 91. – №. 6.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Drolet B.A., Frommelt P.C., Chamlin S.L., Haggstrom A., Bauman N.M., Chiu Y.E. et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013; 131(1): 128–40. doi: 10.1542/peds.2012-1691. 4</mixed-citation><mixed-citation xml:lang="en">Drolet B.A., Frommelt P.C., Chamlin S.L., Haggstrom A., Bauman N.M., Chiu Y.E. et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013; 131(1): 128–40. doi: 10.1542/peds.2012-1691. 4</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Heyer G.L. PHACE(S) syndrome. Handb. Clin. Neurol. 2015; 132: 169–83. doi: 10.1016/B978-0-444-62702-5.00012-3.</mixed-citation><mixed-citation xml:lang="en">Heyer G.L. PHACE(S) syndrome. Handb. Clin. Neurol. 2015; 132: 169–83. doi: 10.1016/B978-0-444-62702-5.00012-3.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Шептий О.В., Круглова Л.С. Младенческая гемангиома: классификация, клиническая картина и методы коррекции //Российский журнал кожных и венерических болезней. – 2016. – Т. 19. – №. 3.</mixed-citation><mixed-citation xml:lang="en">Шептий О.В., Круглова Л.С. Младенческая гемангиома: классификация, клиническая картина и методы коррекции //Российский журнал кожных и венерических болезней. – 2016. – Т. 19. – №. 3.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Holland K.E., Drolet B.A. Approach to the patient with an infantile hemangioma. Dermatol. Clin. 2013; 31(2): 289–301.</mixed-citation><mixed-citation xml:lang="en">Holland K.E., Drolet B.A. Approach to the patient with an infantile hemangioma. Dermatol. Clin. 2013; 31(2): 289–301.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chen T.S., Eichenfi eld L.F., Friedlander S.F. Infantile hemangiomas: an update on pathogenesis and therapy. Pediatrics. 2013; 131(1): 99–108.</mixed-citation><mixed-citation xml:lang="en">Chen T.S., Eichenfi eld L.F., Friedlander S.F. Infantile hemangiomas: an update on pathogenesis and therapy. Pediatrics. 2013; 131(1): 99–108.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">grls.rosminzdrav.ru данные от 06.02.2020.</mixed-citation><mixed-citation xml:lang="en">grls.rosminzdrav.ru данные от 06.02.2020.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">https://www.hemangeol.com/parent/ данные от 06.02.2020.</mixed-citation><mixed-citation xml:lang="en">https://www.hemangeol.com/parent/ данные от 06.02.2020.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hogeling M., Adams S., Wargon O. A randomized controlled trial of propran¬olol for infantile hemangiomas. Pediatrics. 2011;128(2):e259–66.</mixed-citation><mixed-citation xml:lang="en">Hogeling M., Adams S., Wargon O. A randomized controlled trial of propran¬olol for infantile hemangiomas. Pediatrics. 2011;128(2):e259–66.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Georgountzou A., Karavitakis E., Klimentopoulou A., Xaidara A., Kakourou T. Propranolol treatment for severe infantile hemangiomas: a single-centre.</mixed-citation><mixed-citation xml:lang="en">Georgountzou A., Karavitakis E., Klimentopoulou A., Xaidara A., Kakourou T. Propranolol treatment for severe infantile hemangiomas: a single-centre.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Data on fi le Pierre Fabre Pharmaceuticals inc.2014 https://www.hemangeol.com/parent/ данные от 06.02.2020.</mixed-citation><mixed-citation xml:lang="en">Data on fi le Pierre Fabre Pharmaceuticals inc.2014 https://www.hemangeol.com/parent/ данные от 06.02.2020.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Marqueling A.L., Oza V., Frieden I.J., Puttgen K.B. Propranolol and infantile hemangiomas four years later: a systemic review. Pediatr. Dermatol. 2013;30(2):182–91.</mixed-citation><mixed-citation xml:lang="en">Marqueling A.L., Oza V., Frieden I.J., Puttgen K.B. Propranolol and infantile hemangiomas four years later: a systemic review. Pediatr. Dermatol. 2013;30(2):182–91.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Admani S., Feldstein S., Gonzalez E.M., Friedlander S.F. Beta blockers: an innovation in the treatment of infantile hemangiomas. J. Clin. Aesthet. Dermatol. 2014;7(7):37–45.</mixed-citation><mixed-citation xml:lang="en">Admani S., Feldstein S., Gonzalez E.M., Friedlander S.F. Beta blockers: an innovation in the treatment of infantile hemangiomas. J. Clin. Aesthet. Dermatol. 2014;7(7):37–45.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Инструкция по медицинскому применению препарата Гемангиол, ЛП- 003301-101115.</mixed-citation><mixed-citation xml:lang="en">Инструкция по медицинскому применению препарата Гемангиол, ЛП- 003301-101115.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
